Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Dec 30;15(12):e0244555. doi: 10.1371/journal.pone.0244555

Global health security and universal health coverage: Understanding convergences and divergences for a synergistic response

Yibeltal Assefa 1,*, Peter S Hill 1, Charles F Gilks 1, Wim Van Damme 2, Remco van de Pas 2, Solomon Woldeyohannes 1, Simon Reid 1
Editor: Irene Agyepong3
PMCID: PMC7773202  PMID: 33378383

Abstract

Background

Global health security (GHS) and universal health coverage (UHC) are key global health agendas which aspire for a healthier and safer world. However, there are tensions between GHS and UHC strategy and implementation. The objective of this study was to assess the relationship between GHS and UHC using two recent quantitative indices.

Methods

We conducted a macro-analysis to determine the presence of relationship between GHS index (GHSI) and UHC index (UHCI). We calculated Pearson’s correlation coefficient and the coefficient of determination. Analyses were performed using IBM SPSS Statistics Version 25 with a 95% level of confidence.

Findings

There is a moderate and significant relationship between GHSI and UHCI (r = 0.662, p<0.001) and individual indices of UHCI (maternal and child health and infectious diseases: r = 0.623 (p<0.001) and 0.594 (p<0.001), respectively). However, there is no relationship between GHSI and the non-communicable diseases (NCDs) index (r = 0.063, p>0.05). The risk of GHS threats a significant and negative correlation with the capacity for GHS (r = -0.604, p<0.001) and the capacity for UHC (r = -0.792, p<0.001).

Conclusion

The aspiration for GHS will not be realized without UHC; hence, the tension between these two global health agendas should be transformed into a synergistic solution. We argue that strengthening the health systems, in tandem with the principles of primary health care, and implementing a “One Health” approach will progressively enable countries to achieve both UHC and GHS towards a healthier and safer world that everyone aspires to live in.

Background

The pandemic of Coronavirus Disease 2019 (COVID-19) is a timely reminder of the nature and impact of emerging infectious diseases that are public health emergencies (PHEs) of international concern [1]. Public health emergencies are defined as "occurrence or imminent threat of an illness or health condition caused by epidemic or pandemic disease, bio terrorism, or (a) novel and highly fatal infectious agent or biological toxin, that poses a substantial risk of a significant number of human fatalities or incidents or permanent or long-term disability” [2]. They have increasingly captured the attention of global health and security communities, and become an emergent theme in recent academic and policy discourses [3, 4]. Various approaches, strategies and programs have been developed to address PHEs at national and global levels, including initiatives to strengthen public health preparedness and global health security (GHS), which represent the proactive and reactive efforts required to protect the world’s population from PHEs [5].

The key global strategy to achieve GHS is implementation of the International Health Regulations (IHR), which is the international law on public health that provides guidance on how human societies should govern their vulnerabilities to PHEs [6]. International Health Regulations require all countries to improve capacity in prevention, early detection, and timely and effective response to the international spread of disease [7]. The 2014 Ebola virus disease outbreak in west Africa brought renewed attention to GHS towards strengthening core public health capacities according to IHR (2005) [3, 8]. Therefore, the GHS Agenda (GHSA) came about as an international collaborative effort among governments and across sectors to strengthen the implementation of the IHR (2005) [9]. The GHSA is based on a “One Health” approach to health security [10], recognizing that the health of people is connected to the health of animals and the environment. Nearly two-thirds of known pathogens and three-quarters of newly emerging pathogens spread from animals to humans [11].

In 2018, the World Health Organization (WHO) released its 13th general programme of work, which aims to promote health, keep the world safe, serve the vulnerable, sets out priorities towards ensuring healthy lives and promoting well-being for all at all ages by: achieving universal health coverage (UHC)–one billion more people benefitting from UHC; addressing health emergencies—one billion more people better protected from health emergencies; and promoting healthier populations—one billion more people enjoying better health and well-being [12]. These strategic priorities require implementation that is jointly reinforcing [13].

However, there is insufficient reconciliation [14], and tension between GHS and UHC conceptualisation, strategy and implementation [15, 16]. In addition, there are disagreements within the broader GHS community on security from what kind of health threat and for whom [4]. In this situation, one should ask: how can we establish and strengthen synergistic systems that will provide health security to everyone [17]?

The objective of this study is to assess the relationship between GHS and UHC by determining their correlation using two recent quantitative indices. Currently, UHC is monitored by the UHC index (UHCI) [18, 19] and GHS by the GHS index (GHSI) [20]. By doing that, we will identify how countries and the global health community can achieve both GHS and UHC (without undermining the other) towards a healthier and safer world.

Methods

Data sources

The GHS index (GHSI, the John Hopkins University) is a composite measure to assess a country’s capability to prevent, detect, and respond to epidemics and pandemics. It is calculated using a framework based on 140 questions organized across six categories: (1) Prevention (prevention of the emergence or release of pathogens); (2) Detection and reporting (early detection and reporting for epidemics of potential international concern); (3) Rapid response (rapid response to and mitigation of the spread of an epidemic); (4) Health system (sufficient and robust health system to treat the sick and protect health workers); (5) Compliance with international norms (commitments to improving national capacity, financing plans to address gaps, and adhering to global norms); and, (6) Risk environment (overall risk environment and country vulnerability to biological threats) [20]. The GHSI is calculated using 140 questions, 34 indicators and 85 sub-indicators, which rely entirely on open-source data from countries. The overall score (0–100) for each country is a weighted sum of the category scores (prevention (16.3%), detection (19.2%), response (19.2%), health systems (16.7%), compliance (15.8%) and risk (12.8%)) assigned by International Panel of Experts. A score of 100 does not indicate that a country has perfect national health security conditions; likewise, a score of 0 does not mean that a country has no capacity. Scores of 0 and 100 represent the least and the most, respectively, favourable health security conditions [20].

The UHC services coverage index (UHCI, WHO) is calculated as the geometric mean of the coverage of essential services based on 17 tracer indicators from the following four categories: (1) reproductive, maternal, newborn and child health; (2) infectious diseases; (3) non-communicable diseases; and, (4) service capacity and access and health security. All indicators are structured so they occur on a scale of 0 to 100%. The UHCI is constructed from geometric means of component indicators in two steps: first, within each of the four categories, and then across those category-specific means. A simple equal weighting approach was utilized when computing the index [18]. Due to data limitations, not all tracer indicators used to compute the index are direct measures of service coverage. Hence, the selected tracer indicators are meant to represent the broad range of essential health services necessary to monitor the progress towards UHC [19].

Data analysis

We prepared a table consisting of the indictors for UHCI in the first column and for GHSI in the second column with the intention to identify areas of overlap and non-overlap of the different indicators for these two indices. We summarized the UHCI and the GHSI data for the six regions of the world, using Microsoft Excel Sheet 2016, to identify the levels of and differences in UHCI and GHSI across the different regions of the world. We calculated Pearson’s correlation coefficient to assess the relationship between the UHCI and GHSI for all included countries (183 in both indices) and the coefficient of determination to estimate how much UHCI can explain the variability in GHSI. List-wise deletion is used to manage the missing data. Analyses were performed using IBM SPSS Statistics Version 25 with a 95% level of confidence.

The findings of the study are structured and presented in order to: (1) identify the presence of convergence and/or divergence between UHC and GHS, and (2) assess GHS “for whom” and “from what”. First, we will describe the concordance and discordance of the indicators for UHCI and GHSI. Second, we will analyse the level and equity of UHCI and GHSI across the six WHO regions. Third, we will assess the relationship between UHCI and GHSI. Finally, we will identify “for whom” and “from what” GHS is designed to provide security.

Findings

Concordance of indicators for universal health coverage and global health security

Table 1 presents the indicators for UHC and GHS. The table demonstrates that there is substantial concordance (overlap) in the indicators used to calculate UHCI and GHSI. There are many areas of overlap (in immunization, infection diseases, and service capacity areas of UHC indicators and prevention, detection, response, health systems and compliance indicators of GHS) and few divergences (family planning, ANC delivery and NCD services indicators of UHC and some of the prevention, detection, response and Risk environment indicators of GHS). None of the indicators for non-communicable diseases in the UHCI are included in the list of indicators in the GHSI. It is also visible that there are few indicators for UHCI (only 17) compared to GHSI (34 indicators and 85 sub-indicators). Of course, the health security (compliance with the IHR) indicator of UHCI is by itself an index for international health security preparedness, and it consists of the majority of the indicators used to estimate the GHSI.

Table 1. Mapping universal health coverage and global health security indicators: Areas of concordance and discordance*.

Universal Health Coverage Global Health Security
Reproductive, maternal, newborn and child health: Prevention: assess antimicrobial resistance, zoonotic disease, biosecurity, biosafety, dual-use research and culture of responsible science, and immunization. Detection and reporting: assess laboratory systems; real-time surveillance and reporting; epidemiology workforce; and data integration between the human, animal, and environmental health sectors. Rapid response: assess emergency preparedness and response planning, exercising response plans, emergency response operation, linking public health and security authorities, risk communication, access to communications infrastructure, and trade and travel restrictions. Health system: assess health capacity in clinics, hospitals, and community care centers; medical countermeasures and personnel deployment; healthcare access; communications with healthcare workers during a public health emergency; infection control practices and availability of equipment; and capacity to test and approve new countermeasures. Compliance with international norms: assess IHR reporting compliance and disaster risk reduction; cross-border agreements on public health emergency response; international commitments; completion and publication of WHO JEE and the World Organisation for Animal Health (OIE) Performance of Veterinary Services (PVS) Pathway assessments; financing; and commitment to sharing of genetic and biological data and specimens. Risk environment: assess political and security risk; socioeconomic resilience; infrastructure adequacy; environmental risks; and public health vulnerabilities that may affect the ability of a country to prevent, detect, or respond to an epidemic or pandemic and increase the likelihood that disease outbreaks will spill across national borders.
• Family planning
• Antenatal and delivery care
• Full child immunization
• Health-seeking behaviour for pneumonia.
Infectious diseases:
• Tuberculosis treatment
• HIV antiretroviral treatment
• Hepatitis treatment
• Use of insecticide-treated bed nets for malaria prevention
• Adequate sanitation
Non-communicable diseases:
• Prevention and treatment of raised blood pressure
• Prevention and treatment of raised blood glucose
• Cervical cancer screening
• Tobacco (non-)smoking.
Service capacity and access:
• Basic hospital access
• Health worker density
• Access to essential medicines
• Health security: compliance with the international health regulations.
*Indicators present in only UHC Indicators present in only GHS Indicators present in both UHC and GHS

Source: Global Health Security Index 2019 (https://www.ghsindex.org/) and World Health Organization(https://www.who.int/data/gho/data/themes/universal-health-coverage).

Global health security

The distribution of health security preparedness

Collectively, global preparedness for health security is quite weak: the average GHSI is 40.2 (out of a possible 100) while it is 51.9 (out of a possible 100) among high-income countries. Table 2 shows that the GHSI is variable across the different WHO regions. The index is highest in Europe (51%) and lowest in Africa (31%). Among the categories of the index, the health system capacity has the lowest index (26%) and compliance with international norms has the highest index (49%).

Table 2. Level of global health security in the six WHO regions, 2019.
WHO regions Global Health Security Index by Category
Average Prevention Detection and reporting Rapid response Health system Compliance with international norms Risk and vulnerability
Africa 31% 25% 32% 31% 15% 47% 59%
Americas 41% 35% 41% 38% 25% 51% 42%
South-East Asia 40% 35% 43% 41% 27% 48% 51%
Europe 51% 49% 56% 46% 40% 54% 32%
Eastern Mediterranean 35% 30% 36% 36% 22% 40% 53%
Western Pacific 38% 29% 37% 39% 24% 44% 41%
Global 40% 35% 42% 38% 26% 49% 45%

Source: Global Health Security Index 2019: https://www.ghsindex.org/.

Countries with a high risk of GHS threats have a low capacity for GHS

Fig 1 shows that there are countries with a high risk of GHS threats, but have a low capacity for GHS. There is a significant and negative correlation between risk environment (risk and vulnerability) and capacity for GHS (r = -0.604, p<0.001).

Fig 1. Scatter plot of risk of GHS threats and capacity for GHS in 183 countries.

Fig 1

GHS: Global Health Security. Source: Global Health Security Index 2019 (https://www.ghsindex.org/).

Universal health coverage

Table 3 shows the average UHCI is 66%; it is highest in Americas region (79%), and lowest in African region (46%).

Table 3. Level of universal health coverage index in the six WHO regions, 2018, in 183 countries.

WHO region Universal Health Coverage Index
UHC index of service coverage Reproductive, maternal, newborn and child health Infectious diseases Non-communicable diseases Service capacity and access
Africa 46% 54% 42% 71% 30%
Americas 79% 84% 72% 71% 90%
South-East Asia 56% 71% 45% 63% 50%
Europe 77% 86% 73% 61% 94%
Eastern Mediterranean 57% 66% 45% 61% 60%
Western Pacific 77% 85% 69% 65% 95%
Global 66% 75% 58% 65% 70%

Global health security and universal health coverage

There is a moderate and significant relationship between UHC index and GHS index

There was a significant relationship between UHCI and GHSI (r = 0.662, p <0.001) (see Fig 2). The UHCI alone explains more than 43% of the variability in GHSI. The remaining 57% of the variability is explained by other factors which are not captured by the UHCI.

Fig 2. Scatter plot of universal health coverage index and global health security index in 183 countries.

Fig 2

GHSI: Global Health Security Index; UHCI: Universal Health Coverage Index. Source: Global Health Security Index 2019 (https://www.ghsindex.org/) and World Health Organization(https://www.who.int/data/gho/data/themes/universal-health-coverage).

Countries with a high risk of GHS threats have a low capacity for UHC

Countries with a high risk of GHS have a low capacity for UHC. There is a significant and negative correlation between risk environment (risk and vulnerability) and capacity for UHC (r = -0.794, p<0.001). This negative correlation is even stronger than the correlation between risk environment (risk and vulnerability) and capacity for GHS (r = 0.604, p<0.001).

Global health security from what?

Fig 3 shows the correlation between the GHSI and the individual component indices of the UHCI (maternal, neonatal and child health index (MNCHI), infectious diseases index (IDI), non-communicable diseases index (NCDI), and service capacity index). The GHSI is moderately and significantly associated with the MNCHI, IDI and service capacity index (r = 0.623 (p<0.001), 0.594 (p<0.001), 0.638 (p<0.001), respectively). However, there is no relationship between the GHSI and the NCDI (r = 0.063, p>0.05).

Fig 3. Scatter plot of sub-indices of universal health coverage index and global health security index in 183 countries.

Fig 3

GHSI: Global Health Security Index; UHCI: Universal Health Coverage Index; MNCHI: maternal, neonatal and child health; ID: infectious diseases; NCD: non-communicable diseases. Source: Global Health Security Index 2019 (https://www.ghsindex.org/) and World Health Organization(https://www.who.int/data/gho/data/themes/universal-health-coverage).

Outliers: Countries with discordant relationship between universal health coverage index and global health security index

Fig 4 shows that the majority of countries with third and fourth quartiles of UHCI (for maternal and child health and infectious diseases services) have above the median GHSI. The figure also shows that majority of countries with the first and second quartiles of UHCI (for maternal and child health and infectious diseases services) have below the median GHSI. Nevertheless, there are also countries with exceptions to these main findings (Fig 4).

Fig 4. Countries above and below the median GHS index in the four quartiles of UHC index for maternal and child health and infectious diseases services.

Fig 4

UHCMNCH: Universal Health Coverage Index for maternal, Neonatal and Child Health Services; UHCID: Universal Health Coverage Index for Infectious Diseases; GHSI: Global Health Security Index. Source: Global Health Security Index 2019 (https://www.ghsindex.org/) and World Health Organization(https://www.who.int/data/gho/data/themes/universal-health-coverage).

There are four groups of countries with a discordant (incongruous) relationship between their UHCI and GHSI: (1) countries (such as Ethiopia, Uganda, Vietnam, India and Indonesia) have GHSI scores above the median but UHCI scores in the first quartile; (2) countries (such as Philippines, Cambodia and Kenya) have GHSI scores above the median but UHCI scores in the second quartile; (3) countries (such as Fiji, Venezuela and Algeria) have GHSI scores below the median but UHCI scores in the third quartile; and (4) countries (such as Cuba and North Korea) have UHCI scores more than the median but GHSI scores less than the median.

Discussion

This study has identified that there is inadequate global capacity for health security; no country or region is fully prepared for GHS; countries with high risk from GHS threats have lower capacity for GHS and UHC; UHCI is significantly associated with GHSI; however, UHC explains only 43% of the variability in GHSI; and NCDI is not correlated with GHSI. Other studies also reported similar findings. Nirmal K, et al. conveyed that countries vary widely in their abilities to prevent, detect, and control new infectious outbreaks. One-third of the 182 countries analysed have limited capacities to prevent, detect and respond to outbreaks of infectious diseases [21]. A study by Oppenheim B, et al. also demonstrates that countries with higher risk and vulnerability have a lower capacity than others. There is overlap of areas with ‘low GHS preparedness’ and ‘high disease emergence risk’ [22].

However, risks to health security can easily be transmitted from one place to another; as a result, epidemics can easily become pandemics. The current epidemic of COVID-19 shows that an outbreak in one district of a country will become a national and then global health security issue, indicating that no country is safe until every country is safe [23]. Health security is a regional and global public good, which requires a collective responsibility [24]. Compliance with IHR (2005) is a critical step towards an effective and sustainable response to GHS [8]. Countries with weak capacity should have a motivation for national prioritization to build IHR (2005) core capacities for GHS. These countries also have a strong case for external assistance until they are able to prevent, detect and respond to PHEs. If the IHR (2005) capacity in countries is systematically and proactively coordinated and managed, the benefits of investments in one country will extend to the wider region or the globe [25]. This will enable us to create a collective capacity which can also be utilized by other countries to contain and mitigate epidemics before they become pandemics. This has the implication that health security requires a regional and global level response, management and coordination, in addition to the national level response [26, 27].

These endeavours require a new financing strategy. It is time that we establish and/ or strengthen a global health security insurance mechanism that pools capacity in both cash and kind to prevent, detect and respond to health emergencies happening anywhere in the globe. It should be generated from different sectors and organizations to support the implementation of the “One Health” approach towards GHS and safer world. The World Bank’s Pandemic Emergency Financing Facility is such a mechanism that provides supplemental financing for responding to potential pandemics [28]. However, this World Bank’s Pandemic Emergency Financing Facility is struggling to deliver on its innovative promise. Therefore, a reform is required so that it can contribute towards an effective and sustainable GHS response [28].

The moderate and significant correlation between the overall UHCI and GHSI implies that changes in one will lead to changes in the other. Implementation of initiatives for GHS, such as IHR (2005), helps countries to address everyday health challenges from endemic diseases [29]. It is therefore appropriate for global health organizations and countries to undertake more joint and strategic planning with a focus on both UHC and GHS [30]. Global health security is more easily achieved when all people can obtain the health services they need without suffering financial hardship” [31]. The attainment of UHC is crucial to establish a first-line of defence against threats to health security. Initiatives and strategies towards UHC will also build capacity towards health security, including in the prevention and control of emerging diseases. Inadequate UHC in one country may cause population movements through borders to seek care in neighbouring countries. This will increase the risk for the spread of infections to other countries. There are reports that Ebola also scattered in west Africa due to population movements across borders in search of health services [32].

Universal health coverage can also be a means to strengthen social solidarity and enhance human (health) security [33]. Achievement of the financial protection goal of UHC can be an effective strategy to prevent poverty (by avoiding catastrophic expenditure or impoverishment) which will in turn ensure health security. Thailand was able to reduce annual impoverishment from medical costs from 2·71% to 0·49% in 10 years by providing UHC to its population [34]. This has implications that UHC reduces poverty and inequity, which are linked to national, human and health security [35].

Achieving UHC requires strong health systems, designed according to the primary health care (PHC) approach, which facilitates the provision of a continuous and comprehensive care closer to the community by addressing both the supply and demand sides of health care. This will be possible only if there is a political commitment to enhance the three pillars of PHC: universal access to quality health services, empowered people and communities, and multisectoral policy and action for health [36, 37]. Strong health systems are also vital to achieve health security. The Ebola crisis in west Africa in 2014 occurred in countries with weak health systems and low levels of UHC. The lack of access to primary care fuelled the spread of the epidemic in these countries [38]. The current epidemic of coronavirus disease 2019 (COVID-19) in China demonstrated the benefit of strong health systems to mitigate the impact of epidemics. There were higher case-fatality rates in Hubei (about 2·9% on average), which had weaker health systems capacity, than the other provinces of China (about 0·7% on average). There was even lower case-fatality rates in the most developed provinces, such as Zhejiang (0 deaths among 1,171 cases) [39, 40]. It is, therefore, important that countries strengthen their health systems, through the PHC approach, [41] to achieve both GHS and UHC [42]. This requires a shift away from vertical (and competitive) tensions to horizontal (and collaborative) solutions between these two global health agendas [43]. A diagonal approach (a proactive and balanced approach that concurrently addresses the requirements of specific priorities while providing opportunities for strengthening health systems) [44] in investments and service delivery will systematically and proactively facilitate this shift from tensions to solutions [45]. This requires political commitment and coordination of stakeholders at all levels [46].

This study also identified that there are areas of convergence and divergence between UHCI and GHSI indicators. The divergences are due to indicators related NCDI, which do not have correlation with GHSI, and activities conducted by institutions outside the health sector. Infectious diseases have been the focus of GHS since the launch of health security initiatives at regional and global levels [6]. The GHSA is skewed to highly virulent IDs and bioterrorist threats, but has neglected NCDs though they are the leading causes of morbidity and mortality worldwide [43, 47]. Horton R. also argued that the world has failed to respond effectively to the rising burden of NCDs due to a pervasive fear that has displaced all other health concerns [48].

We contend that addressing NCDs is crucial for an effective and sustainable GHS response. The risks for NCDs, including behaviours (such as smoking and drinking) and products (such as food, cigarettes and drugs), are shared and transferred from place to place and from person to person [49, 50]. NCDs and IDs share common features, such as long-term care needs and overlapping high-risk populations, and have direct interactions due to increased susceptibility to IDs in individuals with NCDs. A systematic review and meta-analysis on the prevalence of comorbidities in patients with Middle East respiratory syndrome coronavirus (MERS-CoV) indicates that diabetes and hypertension are equally prevalent in approximately 50% of the patients and cardiac diseases and obesity are also present in 30% and 16%, respectively, of the cases. The review recommended that protection against MERS-CoV and other respiratory infections can be improved if public health vaccination strategies are tailored to target persons with chronic disorders [51]. The ongoing outbreak of COVID-19 clearly illustrates the impact of NCDs co-morbidity on the severity of illness and rate of fatal outcome. The results of a single-centre case series showed that patients with severe COVID-19–associated pneumonia, admitted to the ICU, were more likely to have underlying comorbidities [52]. Furthermore, an analysis of 72,314 patient records of confirmed and suspected cases of COVID-19 showed that the case-fatality rate was 5–10 times higher in patients with comorbidities [53].

It is, therefore, relevant and appropriate that Remais JV, et al. advocate for integrated care and surveillance of NCDs and IDs based on the observed convergence of disease burden [54]. Initiatives that advance the prevention and control of NCDs can support the goals of GHS through direct and indirect mechanisms. NCDs prevention and control programs will help reduce the burden of IDs at population level. Moreover, health systems platforms to prevent, detect and respond to NCDs can also be used for the prevention and control of IDs [55]. In addition, reducing the burden of NCDs has a significant positive economic impact that further strengthens the health system for prevention and control of IDs [56]. Therefore, incorporating NCDs with the GHSA efforts can have a synergistic effect towards resilient health systems, which can respond in ordinary and extraordinary times, to ensure human and health security through a multi-sectoral action [35].

The other reason for the divergence between UHCI and GHSI relates to activities outside the health system, such as animal and agriculture sectors. These activities are collectively described as a “One Health” approach to health security [10]. The “One Health” approach supports GHS by improving coordination, collaboration and communication at the human-animal-environment interface to address shared health threats such as zoonotic diseases, antimicrobial resistance and food safety [57].

The GHSA was launched by more than 20 countries, in collaboration with the Centers for Disease Control and Prevention (CDC), the World Health Organization, the World Organisation for Animal Health and the Food and Agriculture Organization, to coordinate action and promote GHS as an international security priority [55]. A GHSA demonstration project in Uganda confirmed substantial improvements to the ability of the country’s public health system to detect and respond to health threats [58]. A similar project in Vietnam enhanced emergency operation centre, laboratory system and information systems platform [59]. The IHR (2005) joint external evaluation process is also catalysing dialogue and partnership for a multi-sectoral approach to evaluate preparedness for health security [60, 61]. There are also efforts to expand global health activities in partnership with security and foreign policy though there is a concern for the possibility of over securitization of global health [62, 63]. However, much more needs to be done to effectively address human, animal, and environmental health collectively in order to prevent the spread of infectious diseases of global health concern [20]. Currently, fewer than 30% of countries demonstrate the existence of mechanisms for sharing data for human, animal, and wildlife surveillance. There are also land-use changes in many countries, which need to addressed strategically to prevent the emergence of infectious diseases [64].

Overall, this study emphasises the need for countries to have a strong capacity for both UHC and GHS. There are two groups of countries which require especial attention due to the discrepancies in the relationship between UHCI and GHSI. Countries such as Ethiopia, Uganda, and Vietnam have GHSI score above the median but UHCI score below the first quartile. It can be noted that these countries are supported by the GHSA and have benefited from it [65]. Other countries such as Cuba and North Korea have UHCI score more than the median but GHSI score less than the median. These countries are isolated (themselves or by others) from the rest of the world [66], and hence, do not consider GHS as a national priority [67]. We argue that no country is safe until every country is safe, and hence no country should not isolate itself from GHS platforms and activities. We recommend further research to explore and explain the discordances between UHCI and GHSI in these countries.

This study has both strengths and limitations. The strengths of this study are: (1) it is the first of its kind, as there is no empirical study that attempts to systematically validate the relationship between UHC and GHS; (2) it is based on two large data sets from almost all countries around the globe; (3) it provides evidence towards a synergistic response for UHC and GHS; and, (4) it shows areas that the UHC and GHS communities should individually and collectively address to fill the gaps towards achieving the health-related SDG and an equitable and safer world. The limitations of the study are: (1) it is based on index measures that in turn are constructed using different data sources, which may have implications for the quality of the data used and the evidence generated from it; (2) UHCI are constructed based on 17 indicators which do not necessarily show the real picture, as certain key indicators (such as skilled delivery service, malaria treatment, TB diagnosis, cancer treatment) are omitted from the index and hence, this study; (3) UHCI and GHSI share a number of data elements such as service capacity, which are included in the construction of the indices; this may have an effect on the correlation analysis; and, (4) the indices are developed using aggregate data, at country-level, which may have weaknesses related to quality such as accuracy and reliability. Nevertheless, we consider that these limitations are not systematically influencing the results, and that they do not affect the analysis and recommendations of this study.

Conclusion

In conclusion, there is inadequate global preparedness for health security and no country or region is fully prepared for GHS. Effective response to GHS demands a global and regional mechanism that supports and facilitates prevention, detection and response to emergencies at national and regional levels. Moreover, the aspiration for GHS will not be realized without UHC; hence, the tension between GHS and UHC should be transformed into a synergistic planning, financing and implementation, through a diagonal investment and service delivery approach, including differentiated, integrated and community-led services. We argue that strengthening the health systems, in tandem with the principles of PHC (universal access to quality health services, empowered people and communities, and multisectoral policy and action for health), and implementing a “One Health” approach through a multi-sectoral approach will progressively enable countries to realize both UHC and GHS towards a healthier and safer world that everyone aspires to live in.

Data Availability

The minimal data set underlying the results described in the manuscript can be found at: Global Health Security Index 2019: https://www.ghsindex.org/ and World Health Organization: https://www.who.int/data/gho/data/themes/universal-health-coverage.

Funding Statement

The research was funded by the University of Queensland. The University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.El Zowalaty ME, Järhult JD. From SARS to COVID-19: A previously unknown SARS-CoV-2 virus of pandemic potential infecting humans—Call for a One Health approach. One health (Amsterdam, Netherlands). 2020:100124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organisation (WHO). Humanitarian Health Action: Definitions: emergencies [cited 2020 27 February]. https://www.who.int/hac/about/definitions/en/.
  • 3.Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. The Lancet. 2015;385(9980):1884–901. 10.1016/S0140-6736(15)60858-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rushton S. Global health security: Security for whom? Security from what? Political Studies. 2011;59(4):779–96. [Google Scholar]
  • 5.Rose DA, Murthy S, Brooks J, Bryant J. The evolution of public health emergency management as a field of practice. American journal of public health. 2017;107(S2):S126–S33. 10.2105/AJPH.2017.303947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fidler DP. From international sanitary conventions to global health security: the new International Health Regulations. Chinese Journal of International Law. 2005;4(2):325–92. [Google Scholar]
  • 7.Rodier G, Greenspan AL, Hughes JM, Heymann DL. Global public health security. Emerging infectious diseases. 2007;13(10):1447 10.3201/eid1310.070732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wilson K, Von Tigerstrom B, McDougall C. Protecting global health security through the International Health Regulations: requirements and challenges. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2008;179(1):44–8. 10.1503/cmaj.080516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wolicki SB, Nuzzo JB, Blazes DL, Pitts DL, Iskander JK, Tappero JW. Public health surveillance: at the core of the Global Health Security Agenda. Health security. 2016;14(3):185–8. 10.1089/hs.2016.0002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zinsstag J, Schelling E, Waltner-Toews D, Tanner M. From “one medicine” to “one health” and systemic approaches to health and well-being. Preventive veterinary medicine. 2011;101(3–4):148–56. 10.1016/j.prevetmed.2010.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences. 2001;356(1411):983–9. 10.1098/rstb.2001.0888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.World Health Organization (WHO). Thirteenth general programme of work 2019–2023. The seventy-first world health assembly Geneva (Switzerland): World Health Organization. 2018.
  • 13.Mahjour J, Mirza Z, Rashidian A, Atta H, Hajjeh R, Thieren M, et al. " Promote health, keep the world safe, serve the vulnerable" in the Eastern Mediterranean Region. Eastern Mediterranean Health Journal. 2018;24(4):323–4. [DOI] [PubMed] [Google Scholar]
  • 14.Aldis W. Health security as a public health concept: a critical analysis. Health Policy and Planning. 2008;23(6):369–75. 10.1093/heapol/czn030 [DOI] [PubMed] [Google Scholar]
  • 15.Ooms G, Beiersmann C, Flores W, Hanefeld J, Müller O, Mulumba M, et al. Synergies and tensions between universal health coverage and global health security: why we need a second ‘Maximizing Positive Synergies’ initiative. BMJ Global Health. 2017;2(1):e000217 10.1136/bmjgh-2016-000217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ooms G, Ottersen T, Jahn A, Agyepong IA. Addressing the fragmentation of global health: the Lancet Commission on synergies between universal health coverage, health security, and health promotion. The Lancet. 2018;392(10153):1098–9. [DOI] [PubMed] [Google Scholar]
  • 17.Erondu NA, Martin J, Marten R, Ooms G, Yates R, Heymann DL. Building the case for embedding global health security into universal health coverage: a proposal for a unified health system that includes public health. The Lancet. 2018;392(10156):1482–6. 10.1016/S0140-6736(18)32332-8 [DOI] [PubMed] [Google Scholar]
  • 18.World Health Organization (WHO). Universal health coverage Geneva: WHO; 2017 [cited 2017 27 December]. http://www.who.int/universal_health_coverage/en/
  • 19.Hogan D, Hosseinpoor AR, Boerma T. Developing an index for the coverage of essential health services. Technical note for World health statistics. 2016. [Google Scholar]
  • 20.Johns Hopkins Center for Health Security. Global Health Security Index 2019 [cited 2019 15 November]. https://www.ghsindex.org/.
  • 21.Kandel N, Chungong S, Omaar A, Xing J. Review of Health Security Capacities in Light of 2019-nCoV Outbreak—Opportunities for Strengthening IHR (2005) Implementation. Available at SSRN 3537089. 2020.
  • 22.Oppenheim B, Gallivan M, Madhav NK, Brown N, Serhiyenko V, Wolfe ND, et al. Assessing global preparedness for the next pandemic: development and application of an Epidemic Preparedness Index. BMJ global health. 2019;4(1):e001157 10.1136/bmjgh-2018-001157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Heymann DL, Shindo N. COVID-19: what is next for public health? The Lancet. 2020. 10.1016/S0140-6736(20)30374-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Katz R, Standley CJ. Regional approaches for enhancing global health security. BMC Public Health. 2019;19(3):473 10.1186/s12889-019-6789-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Brown T. ‘Vulnerability is universal’: Considering the place of ‘security’and ‘vulnerability’within contemporary global health discourse. Social Science & Medicine. 2011;72(3):319–26. 10.1016/j.socscimed.2010.09.010 [DOI] [PubMed] [Google Scholar]
  • 26.Gostin LO, Katz R. The International Health Regulations: the governing framework for global health security. The Milbank Quarterly. 2016;94(2):264–313. 10.1111/1468-0009.12186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet. 2015;386(10009):2204–21. 10.1016/S0140-6736(15)00946-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brim B, Wenham C. Pandemic Emergency Financing Facility: struggling to deliver on its innovative promise. BMJ. 2019;367:l5719 10.1136/bmj.l5719 [DOI] [PubMed] [Google Scholar]
  • 29.Frieden TR, Tappero JW, Dowell SF, Hien NT, Guillaume FD, Aceng JR. Safer countries through global health security. The Lancet. 2014;383(9919):764–6. 10.1016/S0140-6736(14)60189-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kluge H, Martín-Moreno JM, Emiroglu N, Rodier G, Kelley E, Vujnovic M, et al. Strengthening global health security by embedding the international health regulations requirements into national health systems. BMJ global health. 2018;3(Suppl 1):e000656 10.1136/bmjgh-2017-000656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.O’Connell T, Rasanathan K, Chopra M. What does universal health coverage mean? The Lancet. 2014;383(9913):277–9. 10.1016/S0140-6736(13)60955-1 [DOI] [PubMed] [Google Scholar]
  • 32.World Health Organization (WHO). Guinea: The Ebola Virus Shows its Tenacity. World Health Organization http://www.who.int/csr/disease/ebola/one-year-report/guinea/en/ Published. 2015.
  • 33.Knaul FM, González-Pier E, Gómez-Dantés O, García-Junco D, Arreola-Ornelas H, Barraza-Lloréns M, et al. The quest for universal health coverage: achieving social protection for all in Mexico. The Lancet. 2012;380(9849):1259–79. 10.1016/S0140-6736(12)61068-X [DOI] [PubMed] [Google Scholar]
  • 34.Evans T, Mushtaque A, Chowdhury R. Thailand’s universal coverage scheme successes and challenges—an independent assessment of the first 10 years (2001–2011). Nonthaburi: Health Insurance System Research Office; 2012. [Google Scholar]
  • 35.Chen L, Narasimhan V. Human security and global health. Journal of Human Development. 2003;4(2):181–90. [Google Scholar]
  • 36.Bloom G. Universal health coverage and primary healthcare: Lessons from Japan: comment on" achieving universal health coverage by focusing on primary care in Japan: Lessons for low-and middle-income countries". International journal of health policy and management. 2017;6(4):229 10.15171/ijhpm.2016.120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Binagwaho A, Ghebreyesus TA. Primary healthcare is cornerstone of universal health coverage. BMJ: British Medical Journal (Online). 2019;365 10.1136/bmj.l2391 [DOI] [PubMed] [Google Scholar]
  • 38.Elliot L. Ebola crisis: global response “has failed miserably”, says World Bank chief. The Guardian. 2014;9. [Google Scholar]
  • 39.Yu M, He S, Wu D, Zhu H, Webster C. Examining the Multi-Scalar Unevenness of High-Quality Healthcare Resources Distribution in China. International journal of environmental research and public health. 2019;16(16):2813 10.3390/ijerph16162813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yunpeng Ji Z M, Peppelenbosch Maikel P, Pan Qiuwei. Potential association between COVID-19 mortality and health-care resource availability. The Lancet Global Health. February 25 2020;Published Online. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Etienne CF. Promoting universal health through primary health care. SciELO Public Health; 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kutzin J, Sparkes SP. Health systems strengthening, universal health coverage, health security and resilience. Bulletin of the World Health Organization. 2016;94(1):2 10.2471/BLT.15.165050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bali S, Taaffe J. The sustainable development goals and the global health security agenda: exploring synergies for a sustainable and resilient world. Journal of public health policy. 2017;38(2):257–68. 10.1057/s41271-016-0058-4 [DOI] [PubMed] [Google Scholar]
  • 44.Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T. The‘diagonal’approach to Global Fund financing: a cure for the broader malaise of health systems? Globalization and health. 2008;4(1):1–7. 10.1186/1744-8603-4-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Assefa Y, Tesfaye D, Van Damme W, Hill PS. Effectiveness and sustainability of a diagonal investment approach to strengthen the primary health-care system in Ethiopia. The Lancet. 2018;392(10156):1473–81. 10.1016/S0140-6736(18)32215-3 [DOI] [PubMed] [Google Scholar]
  • 46.Kieny MP, Bekedam H, Dovlo D, Fitzgerald J, Habicht J, Harrison G, et al. Strengthening health systems for universal health coverage and sustainable development. Bulletin of the World Health Organization. 2017;95(7):537 10.2471/BLT.16.187476 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Stevenson MA, Moran M. Health security and the distortion of the global health agenda Routledge handbook of global health security: Routledge; 2014. p. 344–54. [Google Scholar]
  • 48.Horton R. Offline: NCDs—why are we failing? The Lancet. 2017;390(10092):346 10.1016/S0140-6736(17)31919-0 [DOI] [PubMed] [Google Scholar]
  • 49.Zimmet PZ, Alberti KGM. Introduction: Globalization and the non-communicable disease epidemic. Obesity. 2006;14(1):1–3. 10.1038/oby.2006.1 [DOI] [PubMed] [Google Scholar]
  • 50.McMurray C, Smith R. Diseases of globalization: socioeconomic transition and health: Routledge; 2013. [Google Scholar]
  • 51.Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. International Journal of Infectious Diseases. 2016;49:129–33. 10.1016/j.ijid.2016.06.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus—infected pneumonia in Wuhan, China. Jama. 2020. 10.1001/jama.2020.1585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Novel CPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2020;41(2):145 10.3760/cma.j.issn.0254-6450.2020.02.003 [DOI] [PubMed] [Google Scholar]
  • 54.Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of non-communicable and infectious diseases in low-and middle-income countries. International journal of epidemiology. 2013;42(1):221–7. 10.1093/ije/dys135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wenham C, Katz R, Birungi C, Boden L, Eccleston-Turner M, Gostin L, et al. Global health security and universal health coverage: from a marriage of convenience to a strategic, effective partnership. BMJ global health. 2019;4(1):e001145 10.1136/bmjgh-2018-001145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kostova D, Husain MJ, Sugerman D, Hong Y, Saraiya M, Keltz J, et al. Synergies between communicable and noncommunicable disease programs to enhance global health security. Emerging infectious diseases. 2017;23(Suppl 1):S40 10.3201/eid2313.170581 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Sinclair J. Importance of a One Health approach in advancing global health security and the Sustainable Development Goals. Revue scientifique et technique (International Office of Epizootics). 2019;38(1):145 10.20506/rst.38.1.2949 [DOI] [PubMed] [Google Scholar]
  • 58.Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P, Aceng J, et al. Rapidly building global health security capacity—Uganda demonstration project, 2013. MMWR Morbidity and mortality weekly report. 2014;63(4):73 [PMC free article] [PubMed] [Google Scholar]
  • 59.Phu TD, Long VN, Hien NT, Lan PT, Lowe W, McConnell MS, et al. Strengthening global health security capacity—Vietnam demonstration project, 2013. MMWR Morbidity and mortality weekly report. 2014;63(4):77 [PMC free article] [PubMed] [Google Scholar]
  • 60.Karesh WB, Cook RA. One world—one health. Clinical medicine. 2009;9(3):259–60. 10.7861/clinmedicine.9-3-259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Forzley M. Global Health Security Agenda: joint external evaluation and legislation—a 1-year review. Health security. 2017;15(3):312–9. 10.1089/hs.2017.0013 [DOI] [PubMed] [Google Scholar]
  • 62.Feldbaum H, Patel P, Sondorp E, Lee K. Global health and national security: the need for critical engagement. Medicine, conflict and survival. 2006;22(3):192–8. 10.1080/13623690600772501 [DOI] [PubMed] [Google Scholar]
  • 63.Wenham C. The oversecuritization of global health: changing the terms of debate. International Affairs. 2019;95(5):1093–110. [Google Scholar]
  • 64.Kelly TR, Karesh WB, Johnson CK, Gilardi KV, Anthony SJ, Goldstein T, et al. One Health proof of concept: Bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human-wild animal interface. Preventive veterinary medicine. 2017;137:112–8. 10.1016/j.prevetmed.2016.11.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Global Health Security Agenda (GHSA). Global Health Security Agenda (GHSA) 2024 Framework. Kampala: November 2018.
  • 66.Gordy K, Lee JSE. Rogue specters: Cuba and North Korea at the limits of US hegemony. Alternatives. 2009;34(3):229–48. [Google Scholar]
  • 67.McInnes C, Lee K. Health, security and foreign policy. Review of international studies. 2006;32(1):5–23. [Google Scholar]

Decision Letter 0

Irene Agyepong

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

24 Sep 2020

PONE-D-20-11383

Global Health Security and Universal Health Coverage: Understanding Convergences and Divergences for a Synergistic Response

PLOS ONE

Dear Dr. Assefa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please make sure that all reviewers comments have been clearly addressed or a rebuttal provided. 

==============================

Please submit your revised manuscript by Nov 08 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Irene Agyepong

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Thank you for stating the following financial disclosure:

"No"

At this time, please address the following queries:

a)    Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)    State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)     If any authors received a salary from any of your funders, please state which authors and which funders.

d)     If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

* Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a relevant ecological study that involved 183 countries. The study assessed the relationship between GHS and UHC by examining their association using two recent quantitative indices. However, this study should undergo a major review before considering it for publication.

(1) The authors should replace “association” with “relationship”

(2) It was not clear if the authors covered the following areas (First, we will describe the concordance and discordance of the indicators for UHCI and GHSI. Second, we will analyze the level and equity of UHCI and GHSI across the six WHO regions. Third, we will assess the association between UHCI and GHSI) in the statistical analysis section.

(3) The authors should consider applying control-chart to explain the outliers and countries above and below the median GHS index and UHC index for maternal and child health and infectious diseases. Deploying this method will enable the authors to identify special- and common-cause variation.

(4) It will be more relevant if the authors can examine what made some countries to have discordant associations between universal health coverage index and global health security index.

(5) How did the authors manage missing data?

(6) This is an ecological study that used aggregate data at country-level. Thus I will advise the authors to highlight other important weaknesses of this study.

Reviewer #2: This is a relevant study that aimed to assess the relationship between GHS and UHC by determining their association using two recent quantitative indices (GHSI and UHCI). The authors identified the presence of convergence and/or divergence between UHC and GHS. Lastly, they assessed the association between UHCI and GHSI and identified “for whom” and “from what” GHS is designed to provide security.

Key findings from this study include moderate and significant association between GHSI and UHCI, and no association between GHSI and non-communicable diseases.

The authors conclude that the aspiration for GHS will not be realized without UHC; hence, the tension between these two global health agendas should be transformed into a synergistic solution. They further propose a one health approach as a potential synergistic solution.

While this manuscript is relevant and an easy read, it could be further strengthened by addressing the following comments:

1. The first paragraph of the findings should be included in the methods section.

2. For presentation of the results, it is useful to start with an overview of the number of indicators per index before describing concordance and discordance.

3. On page 6, the key categories for measuring GHSI are indicated as prevention, detection, response, health system, compliance, and risk. In table 2 resilience is indicated as a category. Please review and make the necessary correction for consistency.

4. What is the data source for table 2?

5. The visual presentation of all figures needs to be improved.

6. Indicate the data source for all figures and tables as figures and tables must be “stand alone”.

7. How was risk and vulnerability for GHS threats assessed in figure 1?

8. Under section 4.3, the authors report that “The GHSI is most strongly associated with the MNCHI, IDI and service capacity index (r = 0.623, 0.594, 0.638)”. Such values of correlation are more appropriately described as being moderate and not strong.

9. Explain why for figure 4 you choose to analyse the number of countries above and below the median GHS index and UHC index for specifically “maternal and child health and infectious diseases” and not other indices. How does the information in figure 4 link with the text for section 4.4? The heading for section 4.4 seems to suggest a broader analysis not only limited to “maternal and child health and infectious diseases” as indices. Please revise section 4.4 accordingly.

10. There is repetition of points in the first 2 paragraphs of the discussion. Please review the text and summarize as needed to improve readability.

11. The authors discuss that “Countries with weak capacity have a strong case for external

assistance until they are able to prevent, detect and respond to PHEs”. A strong case for national prioritization to detect and respond to PHEs is also very important and must be captured in the statement.

12. The concept of a “one health approach” is introduced in the discussion and discussed in more detail much later in the discussion. The authors need to add a few sentences to explain what this approach means early on.

13. The authors make categorical statements such as “This mechanism will definitely complement the national level health insurance mechanism”. Where is the evidence for this? The authors should be cautious in making such statements without substantiating the point being made- alternatively, such statements can be phrased emphasizing the possibility of expected outcomes as being argued by the authors. There are several of such statements in the discussion and they should be modified accordingly.

14. Please check the discussion for grammatical errors.

15. Please reference and explain what a diagonal approach (as used in the discussion) is e.g. https://www.unicef.org/sowc08/docs/sowc08_panel_2_6.pdf

16. The authors suggest in the discussion that “…. also identified two groups of countries which require especial attention due to the discrepancies in the association between UHCI and GHSI”. The basis for suggesting that these groups of countries require special attention is unfounded. Yes, they need attention but so do the many countries that have poor correlation between UHCI and GHSI. The authors should rephrase the sentence to capture the need for countries to have both a strong UHCI and GHSI.

17. Where are the results of the chi-square and regression analysis in the manuscript?

18. The authors indicate as a limitation that -“UHCI are constructed based on 17 indicators which do not necessarily show the real picture, as certain key indicators might be omitted from the index”. It will be useful to cite examples of these key indicators that may be omitted in text or in an appendix.

19. The authors also cite a limitation of the study as “UHCI and GHSI share a number of data elements such as service capacity, which are included in the construction of the indices; this may have an effect on the correlation analysis”. In what way/how will the correlation analysis be affected due to shared data elements in both UHCI and GHSI?

20. In general, very good points are made and discussed in the discussion section. However, the discussion could benefit from revision to improve its flow, connection of ideas/arguments and grammatical errors.

21. Please review the colour coding for figure 4- usually the red colour is applied where there is cause for concern.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Hannah Brown Amoakoh

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: COMMENTS.docx

PLoS One. 2020 Dec 30;15(12):e0244555. doi: 10.1371/journal.pone.0244555.r002

Author response to Decision Letter 0


6 Oct 2020

Point-by-point response to the comments

Reviewer #1: This is a relevant ecological study that involved 183 countries. The study assessed the relationship between GHS and UHC by examining their association using two recent quantitative indices. However, this study should undergo a major review before considering it for publication.

(1) The authors should replace “association” with “relationship”

We accept the comment. We have replaced “association” with “relationship”.

(2) It was not clear if the authors covered the following areas (First, we will describe the concordance and discordance of the indicators for UHCI and GHSI. Second, we will analyze the level and equity of UHCI and GHSI across the six WHO regions. Third, we will assess the association between UHCI and GHSI) in the statistical analysis section.

We accept the comment. We have provided the data analyses conducted to achieve all of these three objectives (describe the concordance and discordance of the indicators for UHCI and GHSI, analyze the level and equity of UHCI and GHSI across the six WHO regions, and assess the association between UHCI and GHSI).

(3) The authors should consider applying control-chart to explain the outliers and countries above and below the median GHS index and UHC index for maternal and child health and infectious diseases. Deploying this method will enable the authors to identify special- and common-cause variation.

We accept the comment. We have developed a control-chart (Figure 2) to demonstrate outliers. We have also refined Figure 4 and presented separate figures for maternal and child health and infectious diseases.

(4) It will be more relevant if the authors can examine what made some countries to have discordant associations between universal health coverage index and global health security index.

We appreciate the comment. We have provided explanations on pages 16 and 17. These explanations may not be sufficient; however, it will require further research to explore and explain the discordances between UHCI and GHSI in these countries. We have recommended this as a future research priority.

(5) How did the authors manage missing data?

We accept the comment. List-wise deletion is used to manage the missing data.

(6) This is an ecological study that used aggregate data at country-level. Thus I will advise the authors to highlight other important weaknesses of this study.

We accept the comment. We have included quality as an important potential weakness of the aggregate data collected from countries.

Reviewer #2: This is a relevant study that aimed to assess the relationship between GHS and UHC by determining their association using two recent quantitative indices (GHSI and UHCI). The authors identified the presence of convergence and/or divergence between UHC and GHS. Lastly, they assessed the association between UHCI and GHSI and identified “for whom” and “from what” GHS is designed to provide security.

Key findings from this study include moderate and significant association between GHSI and UHCI, and no association between GHSI and non-communicable diseases.

The authors conclude that the aspiration for GHS will not be realized without UHC; hence, the tension between these two global health agendas should be transformed into a synergistic solution. They further propose a one health approach as a potential synergistic solution.

While this manuscript is relevant and an easy read, it could be further strengthened by addressing the following comments:

1. The first paragraph of the findings should be included in the methods section.

We accept the comment. We have moved the first paragraph of the findings to the methods section.

2. For presentation of the results, it is useful to start with an overview of the number of indicators per index before describing concordance and discordance.

We appreciate the comment. We have presented the indicators for each index in the methods section. The indicators can be presented in the findings section. However, we think that the methods section is more appropriate to present the indicators.

3. On page 6, the key categories for measuring GHSI are indicated as prevention, detection, response, health system, compliance, and risk. In table 2 resilience is indicated as a category. Please review and make the necessary correction for consistency.

We agree that the indicator is a bit confusing. We intended to mean resilience for risk to GHS. We have revised the table so that it repeats the nomenclature used in Global Health Security Index (https://www.ghsindex.org/).

4. What is the data source for table 2?

Source: Global Health Security Index 2019. https://www.ghsindex.org/.

5. The visual presentation of all figures needs to be improved.

We accept the comment. We have improved the visual presentation of figures.

6. Indicate the data source for all figures and tables as figures and tables must be “stand alone”.

We accept the comment. We have provided data sources for each table and figure.

7. How was risk and vulnerability for GHS threats assessed in figure 1?

We agree that the indicator is a bit confusing. The Global Health Security Index uses ‘risk and vulnerability’ as its sixth category of indicators. We originally thought that resilience could be translated to mean the opposite of ‘risk and vulnerability’. We have understood from the review that this is confusing. Hence, we preferred to use the original indicator from the source: ‘risk and vulnerability’.

8. Under section 4.3, the authors report that “The GHSI is most strongly associated with the MNCHI, IDI and service capacity index (r = 0.623, 0.594, 0.638)”. Such values of correlation are more appropriately described as being moderate and not strong.

We accept the comment. We have revised the sentence: The GHSI is moderately and significantly associated with the MNCHI, IDI and service capacity index.

9. Explain why for figure 4 you choose to analyse the number of countries above and below the median GHS index and UHC index for specifically “maternal and child health and infectious diseases” and not other indices. How does the information in figure 4 link with the text for section 4.4? The heading for section 4.4 seems to suggest a broader analysis not only limited to “maternal and child health and infectious diseases” as indices. Please revise section 4.4 accordingly.

We preferred to focus on “maternal and child health and infectious diseases” because these are the sub-indices significantly associated with GHSI in contrast to the index for NCDs. Otherwise, we do not have any other reason. We, of course, also analysed and presented the data for the number of countries above and below the median for overall GHSI and overall UHCI.

10. There is repetition of points in the first 2 paragraphs of the discussion. Please review the text and summarize as needed to improve readability.

We accept the comment. We have revised the second paragraph to avoid repetition.

11. The authors discuss that “Countries with weak capacity have a strong case for external

assistance until they are able to prevent, detect and respond to PHEs”. A strong case for national prioritization to detect and respond to PHEs is also very important and must be captured in the statement.

We accept the comment. We have revised and expanded the sentence as follows: Countries with weak capacity have a strong case for national prioritization to build core capacities for GHS according to the IHRs (2005). These countries also have a strong case for external assistance until they are able to prevent, detect and respond to PHEs.

12. The concept of a “one health approach” is introduced in the discussion and discussed in more detail much later in the discussion. The authors need to add a few sentences to explain what this approach means early on.

We accept the comment. We have introduced the concept of “One Health” in the background section.

13. The authors make categorical statements such as “This mechanism will definitely complement the national level health insurance mechanism”. Where is the evidence for this? The authors should be cautious in making such statements without substantiating the point being made- alternatively, such statements can be phrased emphasizing the possibility of expected outcomes as being argued by the authors. There are several of such statements in the discussion and they should be modified accordingly.

We accept the comment. We have revised the paragraph to avoid such unsubstantiated statements. We have also checked for similar statements in the discussion section and revised them.

14. Please check the discussion for grammatical errors.

Thank you for the comment. We have reviewed and edited the manuscript.

15. Please reference and explain what a diagonal approach (as used in the discussion) is e.g. https://www.unicef.org/sowc08/docs/sowc08_panel_2_6.pdf

Thank you for the comment. We have provided a definition for a diagonal approach (a proactive and balanced approach that concurrently addresses the requirements of specific priorities while providing opportunities for strengthening health systems)

16. The authors suggest in the discussion that “…. also identified two groups of countries which require especial attention due to the discrepancies in the association between UHCI and GHSI”. The basis for suggesting that these groups of countries require special attention is unfounded. Yes, they need attention but so do the many countries that have poor correlation between UHCI and GHSI. The authors should rephrase the sentence to capture the need for countries to have both a strong UHCI and GHSI.

We accept the comment. We have revised the paragraph accordingly.

17. Where are the results of the chi-square and regression analysis in the manuscript?

Thank you for this comment. We initially conducted chi-square and regression analyses. However, we decided to drop the findings from these analyses. We have revised the methods section that chi-square and regression analyses are no more included.

18. The authors indicate as a limitation that -“UHCI are constructed based on 17 indicators which do not necessarily show the real picture, as certain key indicators might be omitted from the index”. It will be useful to cite examples of these key indicators that may be omitted in text or in an appendix.

We accept the comment. We have provided examples of indicators (such as such as skilled delivery service, malaria treatment, TB diagnosis, cancer treatment) which we think should be included in the UHCI.

19. The authors also cite a limitation of the study as “UHCI and GHSI share a number of data elements such as service capacity, which are included in the construction of the indices; this may have an effect on the correlation analysis”. In what way/how will the correlation analysis be affected due to shared data elements in both UHCI and GHSI?

A number of indicators such as immunization, health systems (human resources, infrastructure and medicines), and those related to IHC capacities are present in both UHC and GHS. This will result in a collinearity effect as same and similar indicators are present in both indices.

20. In general, very good points are made and discussed in the discussion section. However, the discussion could benefit from revision to improve its flow, connection of ideas/arguments and grammatical errors.

Thank you for the comment. We have reviewed and edited the manuscript.

21. Please review the colour coding for figure 4- usually the red colour is applied where there is cause for concern.

We accept the comment. Thank you. We have changed the colour coding for figure 4.

Attachment

Submitted filename: Rebuttal Letter GHS and UHC PONE October 1 2020.docx

Decision Letter 1

Irene Agyepong

24 Nov 2020

PONE-D-20-11383R1

Global Health Security and Universal Health Coverage: Understanding Convergences and Divergences for a Synergistic Response

PLOS ONE

Dear Dr. Assefa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please make sure you address all the minor revision comments raised by reviewer 1.  

Please submit your revised manuscript by Jan 08 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Irene Agyepong

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you for addressing the comments raised earlier about your manuscript. The manuscript is more clearer now. However, the manuscript could be further improved by addressing the following comments:

1. Include the p-values for all correlation coefficients in the results section to enable readers assess the significance of the associations.

2. You state that the primary health approach is useful in strengthening health systems. It will be useful to remind readers what the basic idea of PHC is and how it relates to strengthening health systems.

3. Under strengths and limitations, you still indicate this …”(3) it uses different analytical approaches (regression analysis and chi-squared statistics) to triangulate the findings of the study;…”. Please remove this statement as you did not perform this analysis.

4. Under the author summary box :What did the researchers do and find? • “We determined the relationship between GHS and UHC by using two recent quantitative indices: UHC index (UHCI) [1, 2] 1,2 and GHS index (GHSI). We conducted correlation and regression analyses”. Please remove the regression analysis as this was not done. Also include the p-values for the results section in the box as you indicate some significant correlations exist.

5. Add p-values to the correlation coefficients in the abstract.

6. In the conclusion you state “…hence, the tension between GHS and UHC should be transformed into a synergistic planning, financing and implementation, through a diagonal investment and service delivery approach”. Explain the term service delivery approach.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Hannah Brown Amoakoh

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 30;15(12):e0244555. doi: 10.1371/journal.pone.0244555.r004

Author response to Decision Letter 1


27 Nov 2020

Dear Dr Irene,

Thank you for giving us the opportunity to improve our manuscript. The comments from the reviewer are very useful and constructive.

We are pleased to submit the third version of our manuscript to PLOS ONE. Following is our point-by-point response to the comments from the reviewers. The comments from the reviewers are shown in Calibri and Italics; our responses are in Calibri, Normal and Bold.

Kind regards,

Dr Yibeltal Assefa

Corresponding author

Point-by-point response to the comments

Review Comments to the Author

Reviewer #2: Thank you for addressing the comments raised earlier about your manuscript. The manuscript is more clearer now. However, the manuscript could be further improved by addressing the following comments:

1. Include the p-values for all correlation coefficients in the results section to enable readers assess the significance of the associations.

We accept the comment. Thank you. The p-values for all correlation coefficients are provided included in the results section.

2. You state that the primary health approach is useful in strengthening health systems. It will be useful to remind readers what the basic idea of PHC is and how it relates to strengthening health systems.

We accept the comment. Thank you. We have provided the basic idea and pillars of PHC as follows: The PHC approach facilitates the provision of a continuous and comprehensive care closer to the community by addressing both the supply and demand sides of health care. This will be possible only if there is a political commitment to enhance the three pillars of PHC: universal access to quality health services, empowered people and communities, and multisectoral policy and action for health.

3. Under strengths and limitations, you still indicate this …”(3) it uses different analytical approaches (regression analysis and chi-squared statistics) to triangulate the findings of the study;…”. Please remove this statement as you did not perform this analysis.

We accept the comment. Thank you. We have removed the statement.

4. Under the author summary box :What did the researchers do and find? • “We determined the relationship between GHS and UHC by using two recent quantitative indices: UHC index (UHCI) [1, 2] 1,2 and GHS index (GHSI). We conducted correlation and regression analyses”. Please remove the regression analysis as this was not done. Also include the p-values for the results section in the box as you indicate some significant correlations exist.

We accept the comment. Thank you. We have removed regression analysis. The p-values for all correlation coefficients are provided.

5. Add p-values to the correlation coefficients in the abstract.

We accept the comment. Thank you. The p-values for all correlation coefficients are provided.

6. In the conclusion you state “…hence, the tension between GHS and UHC should be transformed into a synergistic planning, financing and implementation, through a diagonal investment and service delivery approach”. Explain the term service delivery approach.

We accept the comment. Thank you. We have revised it as follows: service delivery approach, including differentiated, integrated and community-led services.

Attachment

Submitted filename: Rebuttal Letter GHS and UHC PONE November 27 2020.docx

Decision Letter 2

Irene Agyepong

14 Dec 2020

Global Health Security and Universal Health Coverage: Understanding Convergences and Divergences for a Synergistic Response

PONE-D-20-11383R2

Dear Dr. Assefa,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Irene Agyepong

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Irene Agyepong

17 Dec 2020

PONE-D-20-11383R2

Global Health Security and Universal Health Coverage: Understanding Convergences and Divergences for a Synergistic Response

Dear Dr. Assefa:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Irene Agyepong

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: COMMENTS.docx

    Attachment

    Submitted filename: Rebuttal Letter GHS and UHC PONE October 1 2020.docx

    Attachment

    Submitted filename: Rebuttal Letter GHS and UHC PONE November 27 2020.docx

    Data Availability Statement

    The minimal data set underlying the results described in the manuscript can be found at: Global Health Security Index 2019: https://www.ghsindex.org/ and World Health Organization: https://www.who.int/data/gho/data/themes/universal-health-coverage.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES